ZA9725B - 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof - Google Patents

4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof

Info

Publication number
ZA9725B
ZA9725B ZA9725A ZA9725A ZA9725B ZA 9725 B ZA9725 B ZA 9725B ZA 9725 A ZA9725 A ZA 9725A ZA 9725 A ZA9725 A ZA 9725A ZA 9725 B ZA9725 B ZA 9725B
Authority
ZA
South Africa
Prior art keywords
dihydronaphth
isoxazoles
derivatives
Prior art date
Application number
ZA9725A
Other languages
English (en)
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA9725B publication Critical patent/ZA9725B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9725A 1996-01-05 1997-01-02 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof ZA9725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05

Publications (1)

Publication Number Publication Date
ZA9725B true ZA9725B (en) 1997-07-07

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9725A ZA9725B (en) 1996-01-05 1997-01-02 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof

Country Status (14)

Country Link
EP (1) EP0874833A1 (ja)
JP (1) JP3161737B2 (ja)
KR (1) KR100308748B1 (ja)
CN (1) CN1214046A (ja)
AR (1) AR005347A1 (ja)
AU (1) AU710059B2 (ja)
BR (1) BR9612578A (ja)
CA (1) CA2241845C (ja)
HU (1) HUP9903706A3 (ja)
IL (1) IL125197A0 (ja)
NO (1) NO983100L (ja)
NZ (1) NZ325587A (ja)
WO (1) WO1997025317A1 (ja)
ZA (1) ZA9725B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420235A1 (en) * 2000-08-21 2002-02-28 Georgetown University 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
ATE372342T1 (de) * 2002-04-02 2007-09-15 Janssen Pharmaceutica Nv Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
DE60331160D1 (de) * 2002-08-15 2010-03-18 Janssen Pharmaceutica Nv Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva
EP1532155B1 (en) 2002-08-21 2008-02-27 Janssen Pharmaceutica N.V. C6- AND C9-SUBSTITUTED CHROMENO[4,3-c]ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
MX336881B (es) 2009-10-29 2016-02-04 Bristol Myers Squibb Co Compuestos heterociclicos triciclicos.
KR102482825B1 (ko) 2016-09-02 2022-12-29 브리스톨-마이어스 스큅 컴퍼니 치환된 트리시클릭 헤테로시클릭 화합물
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds
US11059784B2 (en) 2017-08-09 2021-07-13 Bristol-Myers Squibb Company Oxime ether compounds
KR102002633B1 (ko) 2018-07-19 2019-07-22 김태효 완충이격부가 구비된 논슬립 발의류
KR102429797B1 (ko) 2019-12-31 2022-08-05 주식회사 제이패션 기능성 무재봉 덧신 및 이를 제조하는 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
WO1994010162A1 (en) * 1992-10-23 1994-05-11 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
HUP9903706A2 (hu) 2000-08-28
EP0874833A1 (en) 1998-11-04
AU1412697A (en) 1997-08-01
JPH11510816A (ja) 1999-09-21
HUP9903706A3 (en) 2000-09-28
AU710059B2 (en) 1999-09-09
WO1997025317A1 (en) 1997-07-17
CA2241845C (en) 2002-10-01
AR005347A1 (es) 1999-04-28
NO983100D0 (no) 1998-07-03
IL125197A0 (en) 1999-03-12
NZ325587A (en) 1999-02-25
KR19990077033A (ko) 1999-10-25
KR100308748B1 (ko) 2001-12-12
NO983100L (no) 1998-09-04
BR9612578A (pt) 1999-07-27
CA2241845A1 (en) 1997-07-17
JP3161737B2 (ja) 2001-04-25
CN1214046A (zh) 1999-04-14

Similar Documents

Publication Publication Date Title
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
IL117859A0 (en) Isothiazolones and their uses
IL120125A0 (en) Substituted oxazolidinones their preparation and their use
IL121298A (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their uses
IL121299A0 (en) 4-hydroxy-piperidine derivatives and their uses
IL111223A (en) 3-phenylmethanoyl benzo [b] thiene derivatives and uses thereof
IL126968A0 (en) Alkylaminobenzothiazole and benzoxazole derivatives
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
ZA9725B (en) 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof
IL131645A (en) Pyrimido ¬1,2-a¾indole derivatives and their preparation
HUP9900400A3 (en) Isoxazole derivatives
HUP9902901A3 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans
AU2405397A (en) Thienopyridine derivatives and their use
HK1023124A1 (en) Oxime derivatives and their use as fungicides
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof
IL113150A0 (en) 1,2,4-triazolo [4,3-a]pyrazin-4-one derivatives and preparation thereof
AU2153197A (en) Cripowellins and synthetic derivatives thereof
HUP9903369A3 (en) 8(9)-dehydroestradiol derivatives
IL117864A0 (en) Benzamidoxime derivatives their preparation and use
ZA973492B (en) Thienopyridine derivatives and their use.
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole